GBA1 and Parkinson disease: Also for the first time we assessed efficiency of NCGC607 treatment on GCase activity and protein levels, as well as glycolipids concentration in peripheral blood mononuclear cells (PBMC)—derived macrophages (cultured macrophages) from patients with GD and GBA-PD with different GBA1 mutations and in iPSCs-derived dopaminergic (DA) neurons from GBA-PD patient.